At a glance
ClinicalIndex Comparison RecordN/AActive· 108 enrolled
Drug / intervention
NETdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
NET Device as a Non-Pharmacological Alternative to Medication for Opioid Withdrawal Symptom Reduction and Abstinence
In Brief
A clinical study evaluating NET for Opioid Use Disorder. Active but no longer recruiting, targeting 108 participants across 1 site.
Detailed Summary
This prospective, randomized, double-blind, parallel-group, sham-controlled, superiority study will evaluate the effectiveness of the NET Device in treating persons with Opioid Use Disorder (OUD) without use of Medications for OUD (MOUD) for persons who have expressed a desire to be opioid abstinent without use of MOUD.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpioid Use Disorder
CountriesUnited States
CollaboratorsNET Recovery Corp, Isaiah House
Timeline
N/AActiveOverdue
20222023202420252026
First PostedJun 2021
Enrollment StartNov 2021
Primary CompletionJul 2023
Study CompletionDec 2025
TodayJul 2026
First PostedJun 7, 2021
Enrollment StartNov 24, 2021
Primary CompletionJul 7, 2023
Study CompletionDec 1, 2025
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 5.1 years ago
Interventions
NETdevice
NET is an investigational device that received CE-Mark in April 2009 as a Class IIa active medical device